EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial ( MiFoot study)

Tolu Onuwe iD, Patrick J Highton iD, David Batchelor, Alan Brennan, Molly Caba, Melanie J Davies iD, Mark P Funnell, Frances Game, Clare L Gillies, Agnieszka Glab, Laura J Gray iD, Edward Gregg und 11 weitere

Diabetic Medicine · 2025

DOI: 10.1111/dme.70028 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Tolu Onuwe und 22 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Foot. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the United Kingdom, the prevalence of diabetes‐related foot ulcer disease (DFUD) is 6.3%, and cardiovascular disease (CVD) is the leading cause of mortality in people with DFUD. This study aims to evaluate the effectiveness of a multifactorial intervention to reduce CVD events and mortality in adults with type 2 diabetes (T2D) and DFUD.

Methods

The MiFoot study is a multi‐centre, pragmatic randomised controlled trial to test intervention effectiveness and cost‐effectiveness compared to usual care that will include an internal feasibility study and a process evaluation. English‐speaking adults (≥18 years; n = 392) with T2D and current/previous (within 5 years) DFUD will be recruited from multiple sites across the United Kingdom and randomised 1:1 to intervention (MiFoot multifactorial intervention plus usual care) or control (usual care), with data collected at baseline, 12‐ and 24‐month follow‐up. The MiFoot intervention comprises an individualised assessment with a healthcare practitioner to optimise treatment and assess the suitability of physical activity participation; group‐based disease self management education and physical activity sessions; and a digital‐based programme, consisting of cohort‐relevant topics, physical activity guidance and peer support functionality. The primary outcome will be extended major adverse cardiovascular events (MACE, i.e. myocardial infarction, stroke, cardiovascular death, peripheral arterial bypass, coronary artery bypass, coronary angioplasty or peripheral artery angioplasty) at 24 months. DISCUSSION This study will provide evidence on the feasibility and clinical effectiveness, and cost‐effectiveness of a multifactorial intervention to prevent or slow the progression of CVD‐related complications in the extremely high‐risk population with T2D and DFUD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic FootAdultFemaleHumansMaleMiddle AgedCost-Benefit AnalysisFeasibility StudiesMulticenter Studies as TopicPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicTreatment OutcomeUnited Kingdom

Stichwörter der Autor:innen

cardiovascular diseasediabetes‐related foot ulcer diseasedigital‐based programmelifestylemortalityphysical activityself management education programme

Autor:innen und Institutionen

  • Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK.
  • National Institute for Health and Care Research Applied Research Collaboration East Midlands, Leicester, UK.
  • Patient and Public Involvement and Engagement Representative, Leicester, UK.
  • School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • National Institute for Health and Care Research Leicester Biomedical Research Centre, Leicester, UK.
  • Department of Research and Development, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

ORCID-Profile: Tolu Onuwe, Patrick J Highton, Melanie J Davies, Laura J Gray, John R Petrie, Dan Pollard, Kamlesh Khunti

Zitieren

APA

Onuwe, T., Highton, P. J., Batchelor, D., Brennan, A., Caba, M., Davies, M. J., Funnell, M. P., Game, F., Gillies, C. L., Glab, A., Gray, L. J., Gregg, E., Hadjiconstantinou, M., Hall, V., Johnson, V., Petrie, J. R., Pollard, D., Rowntree, H., Tesfaye, S., …, & Khunti, K. (2025). A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial ( MiFoot study). Diabetic Medicine. https://doi.org/10.1111/dme.70028

Vancouver

Onuwe T, Highton PJ, Batchelor D, Brennan A, Caba M, Davies MJ, et al. A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial ( MiFoot study). Diabetic Medicine. 2025. doi:10.1111/dme.70028

BibTeX
@article{Onuwe2025,
  author = {Onuwe, Tolu and Highton, Patrick J and Batchelor, David and Brennan, Alan and Caba, Molly and Davies, Melanie J and Funnell, Mark P and Game, Frances and Gillies, Clare L and Glab, Agnieszka and Gray, Laura J and Gregg, Edward and Hadjiconstantinou, Michelle and Hall, Vicky and Johnson, Vicki and Petrie, John R and Pollard, Dan and Rowntree, Hannah and Tesfaye, Solomon and Valabhji, Jonathan and Webb, David and Zaccardi, Francesco and Khunti, Kamlesh},
  title = {A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial ( MiFoot study)},
  journal = {Diabetic Medicine},
  year = {2025},
  doi = {10.1111/dme.70028}
}
Kostenlos starten →